Screening for core binding factor gene rearrangements in acute myeloid leukemia

被引:16
作者
Grimwade, D
机构
[1] UCL Hosp, Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London, England
[2] UCL Hosp, Dept Haematol, London, England
关键词
D O I
10.1038/sj.leu.2402421
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:964 / 969
页数:6
相关论文
共 45 条
[1]   Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: Correlation with cytogenetics, morphology and immunophenotype [J].
Andrieu, V ;
RadfordWeiss, I ;
Troussard, X ;
Chane, C ;
Valensi, F ;
Guesnu, M ;
Haddad, E ;
Viguier, F ;
Dreyfus, F ;
Varet, B ;
Flandrin, G ;
Macintyre, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (04) :855-865
[2]   Typical CBFβ/MYH11 fusion due to insertion of the 3′-MYH11 gene into 16q22 in acute monocytic leukemia with normal chromosomes 16 and trisomies 8 and 22 [J].
Aventín, A ;
La Starza, R ;
Nomdedéu, J ;
Brunet, S ;
Sierra, J ;
Mecucci, C .
CANCER GENETICS AND CYTOGENETICS, 2000, 123 (02) :137-139
[3]  
Bäsecke J, 1999, BLOOD, V94, p657A
[4]  
Bloomfield CD, 1998, CANCER RES, V58, P4173
[5]   Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid:: Result of the randomized MRC trial [J].
Burnett, AK ;
Grimwade, D ;
Solomon, E ;
Wheatley, K ;
Goldstone, AH .
BLOOD, 1999, 93 (12) :4131-4143
[6]   Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial [J].
Burnett, AK ;
Goldstone, AH ;
Stevens, RMF ;
Hann, IM ;
Rees, JKH ;
Gray, RG ;
Wheatley, K .
LANCET, 1998, 351 (9104) :700-708
[7]  
BURNETT AK, 2002, IN PRESS BR J HAEMAT
[8]  
Chillón MC, 2001, HAEMATOLOGICA, V86, P162
[9]  
DASTUGUE N, 1995, LEUKEMIA, V9, P1491
[10]  
Dierlamm J, 1998, GENE CHROMOSOME CANC, V22, P87, DOI 10.1002/(SICI)1098-2264(199806)22:2<87::AID-GCC1>3.0.CO